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Abstract 
In this work synthesis, characterization and crystal structures of two isothiocyanato Fe(III) 
complexes with 2,2’-[2,6-pyridinediylbis(ethylidyne-1-hydrazinyl-2-ylidene)]bis[N,N,N-
trimethyl-2-oxoethanaminium] dichloride (H2LCl2) ligand, with composition 
[FeL(NCS)2]SCN·2H2O and [FeL(NCS)2]2[Fe(H2O)(NCS)5]·4H2O, has been reported. Both 
iron(III) complexes possess the same pentagonal-bipyramidal complex cation, while the nature 
of their anions depends on mole ratio of NH4SCN and FeCl3·6H2O used in reaction. Cytotoxic 
activity of new Fe(III) complexes, as well as of previously synthesized isothiocyanato Co(II), 
Ni(II), Mn(II), Zn(II) and Cd(II) complexes with the same ligand, was tested against five human 
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cancer cell lines (HeLa, MDA-MB-453, K562, LS174 and A549) and normal cell line MRC-5. 
The best activity was observed in the case of Fe(III), Co(II) and Cd(II) complexes. The 
investigation of potential of these complexes to induce HeLa and K562 cell cycle perturbations 
was also evaluated. Mechanism of cell death mode was elucidated on the basis of morphological 
changes of HeLa cells as well as identification of target caspases. It was established that DNA 
damage could be responsible for the activity of Fe(III) and Co(II) complexes. 
 
Keywords: 2,6-diacetylpyridine dihydrazone, pentagonal-bipyramidal, Fe(III) complexes, crystal 
structure, cytotoxicity, DNA interactions 
 
1. Introduction 
The coordination properties of 2,6-diacetylpyridine bis(acylhydrazones) towards 3d metal ions 
[1–5], some lanthanides [1, 6–8], main group [1, 9–11], 4d and 5d elements [1] have been 
intensively studied over the years. The 2,6-diacetylpyridine bis(acylhydrazone) ligands possess 
at least five donor atoms (N3O2) in spatial arrangement which supports formation of seven-
coordinated complexes with pentagonal-bipyramidal (PBPY-7) geometry. Pentagonal-
bipyramidal geometry is the most common, but not exclusive among the reported complexes 
with 2,6-diacetylpyridine bis(acylhydrazone) ligands, and possibility for its formation depends 
on the nature of central metal ion, conformational flexibility of hydrazone ligand and reaction 
conditions [1]. The acidity of hydrazone function in 2,6-diacetylpyridine bis(acylhydrazone) 
ligands contributes to structural versatility of their complexes due to possibility of coordination 
of ligand in non-deprotonated, partially deprotonated and fully deprotonated form [12]. 
Pentagonal-bipyramidal complexes of 2,6-diacetylpyridine bis(acylhydrazone) ligands have a 
wide spectrum of biological activities: cytotoxic [11], antimicrobial [9, 10, 13], SOD mimetic 
[14–16], DNA/RNA binding and nuclease activity [8, 17, 18]. In the previously published papers 
[19–21], synthesis, characterization and antimicrobial activity of 2,2’-[2,6-
pyridinediylbis(ethylidyne-1-hydrazinyl-2-ylidene)]bis[N,N,N-trimethyl-2-oxoethanaminium] 
dichloride (H2LCl2) and its corresponding Mn(II) (1), Ni(II) (2), Co(II) (3 and 4), Zn(II) (5) and 
Cd(II) (6) complexes (Scheme 1) were described. In these complexes the ligand H2LCl2 is 
coordinated in non-deprotonated form via pyridine nitrogen, both imine nitrogen and both 
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carbonyl oxygen atoms. All the complexes possess pentagonal-bipyramidal (PBPY-7) 
coordination geometry with N3O2 coordinated H2LCl2 ligand in equatorial plane of the 
bipyramid and two isothiocyanato ligands in the axial area. The complexes showed a better 
antimicrobial activity than the ligand. Among the complexes the best activity was observed in 
the case of Zn(II) (5) and Cd(II) (6) complexes. As continuation of previous work in this field, in 
the present paper the syntheses and crystal structures of two isothiocyanato Fe(III) complexes (7 
and 8) with H2LCl2 ligand (Scheme 2) are reported. In order to study the influence of the nature 
of central metal ion in isothiocyanato PBPY-7 complexes with H2LCl2 ligand on their biological 
activity, antimicrobial and cytotoxic activity of new Fe(III) complexes (7 and 8) as well as 
cytotoxic activity of previously reported Mn(II) (1), Ni(II) (2), Co(II) (3 and 4), Zn(II) (5) and 
Cd(II) (6) complexes with H2LCl2 ligand were tested. 
 
Scheme 1. Pentagonal-bipyramidal isothiocyanato complexes of Mn(II) (1), Ni(II) (2), Co(II) (3 
and 4), Zn(II) (5) and Cd(II) (6) with H2LCl2 ligand [19–21] 
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2. Experimental 
 
2.1. Materials and methods 
2,6-Diacetylpyridine (99%) and Girard’s T reagent (99%) were obtained from Aldrich. IR 
spectra were recorded on a Nicolet 6700 FT-IR spectrometer using the ATR technique in the 
region 4000−400 cm−1 (s-strong, m-medium, w-weak). Elemental analyses (C, H, and N) were 
performed by standard micro-methods using the ELEMENTARVario ELIII C.H.N.S.O analyzer. 
Molar conductivities were measured at room temperature (25 °C) on a digital conductivity-meter 
JENWAY-4009. 
 
2.2. Synthesis of Mn(II) (1), Ni(II) (2), Co(II) (3 and 4), Zn(II) (5) and Cd(II) (6) complexes 
Pentagonal-bipyramidal isothiocyanato complexes of Mn(II) (1), Ni(II) (2), Co(II) (3 and 4), 
Zn(II) (5) and Cd(II) (6) with H2LCl2 ligand were synthesized according to the previously 
described methods [19−21]. 
 
2.3. Synthesis of [FeL(NCS)2]SCN·2H2O complex (7) 
The ligand H2LCl2 (0.25 mmol, 0.13 g) was dissolved in methanol (20 mL) with heating, then 
FeCl3·6H2O (0.25 mmol, 0.06 g) and NH4SCN (1.00 mmol, 0.08g) were added. The solution was 
heated 3 h at 65 °C. After a few days brownish-red needle-like crystals arose from the reaction 
solution.  
IR: 3501 (m), 3021 (w), 2961 (w), 2055 (s), 1614 (w), 1588 (w), 1542 (m), 1508 (w), 1482 (w), 
1402 (m), 1368 (w), 1337 (m), 1273 (w), 1202 (w), 1152 (m), 1123 (w), 1075 (w), 1024 (w), 
1001 (w), 970 (w), 920 (w), 808 (w), 736 (w), 677 (w). 
Anal. Calcd. for C22H35FeN10O4S3 (%): C, 40.30; H, 5.38; N 21.36; S, 14.67. Found: C, 39.88; 
H, 5.52; N, 21.09; S, 14.64. 
ΛM (1 mM, DMSO): 75.0 Ω–1 cm2 mol–1. 
 
2.4. Synthesis of [FeL(NCS)2]2[Fe(H2O)(NCS)5]·4H2O complex (8) 
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The ligand H2LCl2 (0.25 mmol, 0.13 g) was dissolved in methanol (20 mL) with heating, then 
FeCl3·6H2O (0.50 mmol, 0.11 g) and NH4SCN (4.00 mmol, 0.30 g) were added. The solution 
was heated 3 h at 65 °C. After a few days brownish-red plate crystals arose from the reaction 
solution. 
IR: 3376 (w), 3035 (w), 2040 (s), 1614 (w), 1548 (m), 1479 (w), 1402 (w), 1338 (w), 1270 (w), 
1203 (w), 1151 (w), 1073 (w), 1024 (w), 972 (w), 911 (w), 807 (w), 748 (w), 679 (w). 
Anal. Calcd. for C47H72Fe3N23O9S9 (%): C, 36.20; H, 4.65; N, 20.66; S, 18.50. Found: C, 35.98; 
H, 4.87; N, 20.53; S, 18.46. 
ΛM (1 mM, DMSO): 136.0 Ω–1 cm2 mol–1. 
 
2.5. X-ray crystal structure determination 
Crystal data and refinement parameters of compounds 7 and 8 are listed in Table S1 (see 
Supplementary Information). The X‒ray intensity data were collected at 150 K with Agilent 
SuperNova dual source with Atlas detector equipped with mirror‒monochromated Mo‒Kα 
radiation (λ = 0.71073 Å). The data were processed using CRYSALIS PRO [22]. Both structures 
were solved by direct methods using SIR-92 [23] and refined against F2 on all data by a full-
matrix least squares procedure with SHELXL-97 [24]. All non-hydrogen atoms were refined 
anisotropically. All of the C–H hydrogen atoms were included in the model at geometrically 
calculated positions and refined using a riding model. The hydrogen atoms bonded to water 
oxygen atoms were visible in the last stages of the refinement and were refined with the 
constrained O–H bond length (0.96 Å) and isotropic thermal parameters (1.5 times the thermal 
parameter of the attached oxygen atom). The residual density peak in 8 (3.01 Å from C41) was 
unrefinable and therefore was not included in the model. The sulfur atoms in 8 bonded to C20, 
C21 and C44 of SCN– ligands are disordered over two orientations and were modelled with split 
positions, with the use of PART instruction. Crystallographic data for structures have been 
deposited at the Cambridge Crystallographic Data Centre as supplementary publication CCDC 
1543583 and 1543584 for 7 and 8, respectively. Copies of the structures can be obtained free of 
charge www.ccdc.cam.ac.uk/data_request/cif.  
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2.6. Antimicrobial activity 
Antimicrobial activity of compounds was tested by the broth-microdilution method according to 
the procedure prescribed by the CLSI (Clinical and Laboratory Standards Institute) [25] against 
seven standard strains of bacteria and one strain of yeast Candida albicans (C. Albicans). The 
compounds were dissolved in distilled water and tested within the concentration range of 1000 
μg/mL to 62.5 μg/mL. Antibiotic gentamicin and ciprofloxacin were used as a control for 
bacteria and amphotericin was used for C. albicans. All tests were performed in Müller-Hinton 
broth for the bacterial strains and in Sabouraud dextrose broth for C. albicans. All of the MIC 
determinations were performed in duplicate, and two positive growth controls were included. 
 
2.7. Cytotoxic activity 
The cytotoxic activities of the complexes and their precursor compounds were examined on five 
human cancer cell lines: cervical adenocarcinoma HeLa, breast carcinoma MDA-MB-453, 
chronic myelogenous leukemia K562, colon adenocarcinoma LS174, lung carcinoma A549, and 
normal human lung fibroblasts MRC-5, as described elsewhere [26]. All tested cell lines were 
obtained from the American Type Culture Collection (Manassas, VA, USA). HeLa (2,000 cells 
per well), MDA-MB-453 (3,000 cells per well), LS174 (7,000 cells per well), A549 (5,000 cells 
per well) and MRC-5 (5,000 cells per well) were seeded into 96-well microtiter plates and 20 h 
later the adherent cells were treated with five different concentrations of the tested compounds 
(ranging from 12.5 µM to 200 µM). Nutrient medium only was added to the control cell samples. 
K562 cells (5,000 cells per well) were seeded 2 h before the treatment with compounds. Stock 
solutions of the seven complexes (2–8) were prepared in DMSO at a concentration of 10 mM, 
while stock solutions of tested precursors and complex 1, were prepared in a sterile water at a 
concentration of 10 mM. The final DMSO concentration did not affect cell survival. Cell 
survival was determined by MTT assay after 72 h of continual treatment, according to the 
method of Mosmann [27], which was modified by Ohno and Abe [28] and described previously 
[26].  
Chemotherapy drug cisplatin was used as a positive control in all experiments.  
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2.8. Cell cycle analysis by flow cytometry 
HeLa and K562 cells were treated with IC50 and 2IC50 concentrations of the complexes 4, 6 and 
8 (the applied concentrations were determined after 72 h treatment for each complex) for 24 h.  
After treatment, the cells were collected, washed and fixed in 70 % ethanol, according to 
standard procedure [26, 29]. Cisplatin was used as a positive control. Cell cycle phase 
distributions were determined using a FACSCalibur flow cytometer (BD Biosciences, Franklin 
Lakes, NJ, USA). The analyses of acquired data (10,000 events collected for each gated cell 
sample) were performed using a CELLQuest software (BD Biosciences). Cell cycle distribution 
data are presented as mean±S.D. of three independent experiments. The statistical significance of 
differences between the control and treated cell samples was evaluated using one-way ANOVA 
with Dunnett’s post test. p values below 0.05 were considered statistically significant.  
 
2.9. Fluorescence microscopy 
To examine the mode of cell death induced by the complexes 4, 6 and 8, morphological analysis 
by fluorescence microscopy of HeLa cells stained with a mixture of acridine orange and 
ethidium bromide was performed, according to previously described protocol [26]. Cisplatin was 
used as a positive control. The visualization was done using Carl Zeiss PALM MicroBeam 
microscope with Axio Observer.Z1 and AxioCam MRm camera (filters: Alexa 488 and Alexa 
568).  
 
2.10. Determination of target caspases 
To explore whether complexes 4, 6 and 8 could induce apoptosis in HeLa cells, the percentages 
of subG1 cells in the samples pretreated with caspase inhibitors were determined, as previously 
described by Matić et al. [26]. The specific caspase inhibitors applied at concentration of 40 µM 
were: Z-DEVD-FMK, a caspase-3 inhibitor, Z-IETD-FMK, a caspase-8 inhibitor and Z-LEHD-
FMK, a caspase-9 inhibitor (R&D Systems, Minneapolis, USA).  
 
2.11. Tube formation assay 
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The possible antiangiogenic effects of the complexes 4, 6 and 8 were examined on human 
umbilical vein EA.hy926 cell line using endothelial cell tube formation assay [30,31]. The 
EA.hy926 cells seeded on Corning® Matrigel® basement membrane matrix (Corning: cat. 
number 356234) were treated with sub-toxic IC20 concentrations of the complexes 4, 6 and 8 
(200 µM, 50 µM and 50 µM respectively) for 20 h. Photomicrographs of EA.hy926 cells were 
captured under the inverted phase-contrast microscope. 
 
2.12. DNA binding experiments 
Calf thymus DNA (lyophilized, highly polymerized, obtained from Serva, Heidelberg) (CT-
DNA) was dissolved in Tris buffer (10 mM Tris-HCl pH 7.9) overnight at 4 °C. This stock 
solution was stored at 4 °C and was stable for several days. A solution of CT-DNA in water gave 
a ratio of UV absorbance at 260 and 280 nm, A260/A280 of 1.89–2.01, indicating that DNA was 
sufficiently free of protein. The concentration of DNA (2.86 mg mL−1) was determined from the 
UV absorbance at 260 nm using the extinction coefficient ε260=6600 M−1 cm−1 [32]. The 
complexes of Co(II) (4), Cd(II) (6) and Fe(III) (8) were dissolved in dimethyl sulfoxide in 
concentrations of 10 mM. These solutions were used as stock solutions. 
 
2.12.1. Absorption spectral measurements 
For an UV-Vis measurement, a small volume of a stock solution of the complex of different 
concentrations was added to DNA solution (10 µL of CT-DNA) and the volume was adjusted up 
to 1 mL with 40 mM bicarbonate buffer, pH 8.4. Reaction mixtures were incubated at 37 °C for 
90 min with occasional vortexing. UV–Vis spectra were recorded on a UV-1800 Shimadzu 
UV/Visible spectrophotometer operating from 200 to 800 nm in 1.0 cm quartz cells. Spectra of 
the complexes of the same concentrations were also recorded, as well as spectra of CT-DNA. 
The absorbance titrations were performed at a fixed concentration of the complex and gradually 
increasing concentration of double stranded CT-DNA. The absorbance at 259 nm was monitored 
for each concentration of DNA. The binding constant Kb was determined using the equation (1) 
[33]: 
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[DNA] × (εa – εf)−1 = [DNA] × (εb – εf) −1 + Kb−1 × (εb – εf) −1, (1) 
 
where εa, εf, εb are absorbance/[complex], extinction coefficient of the free complex and the 
extinction coefficient of the bound complex, respectively. A plot of [DNA]/(εa – εf) versus 
[DNA] gave a slope and the intercept equal to 1/(εa – εf) and (1/Kb)(1/(εb – εf)), respectively. The 
binding constant Kb is calculated from the ratio of the slope to the intercept. 
 
2.12.2. Fluorescence measurements 
The competitive interactions of complexes 4, 6 and 8 and the fluorescence probe either ethidium 
bromide (EB) or Hoechst 33258 (H), with CT-DNA have been studied by measuring the change 
of fluorescence intensity of the probe−DNA solution after addition of the complex. Reaction 
mixtures containing 100 µM of CT-DNA (calculated per phosphate) in 1 mL of 40 mM 
bicarbonate solution (pH 8.4) were pretreated with 1.5 µL of 1% H probe solution (28 µM final 
concentration) or 1 µL of 1% EB solution (25 µM final concentration) (in separate experiments) 
for 20 min and the mixture was analyzed by fluorescence measurement. Then the increasing 
concentrations of the complexes were successively added and the changes in the fluorescence 
intensity were measured using a Thermo Scientific Lumina Fluorescence spectrometer (Finland) 
equipped with a 150 W Xenon lamp. The slits on the excitation and emission beams were fixed 
at 10 nm. All measurements were performed by excitation at 350 nm for Hoechst 33258, and by 
excitation at 500 nm for EB in the range of 390−600 nm. The control was probe−CT-DNA 
solution. Complexes of Co(II) (4), Cd(II) (6) and Fe(III) (8) did not have fluorescence under 
applied conditions. The obtained fluorescence quenching data were analyzed according to the 
Stern–Volmer equation (2) [34]: 
 
I0/I = 1 + Kr       (2) 
where I0 and I represent the fluorescence intensities of probe−CT-DNA in absence and presence 
of the complex, respectively, K is quenching constant. The K value is calculated from the ratio of 
the slope to the intercept from the plot of I0/I versus r (r = [complex]/[CT-DNA]. 
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Primary spectra of all spectrometric measurements were imported into OriginPro 8.0 and were 
processed by this software package. 
 
2.12.3. DNA cleavage experiments 
For DNA cleavage experiments the plasmid pUC19 (2686 bp, purchased from Sigma-Aldrich, 
USA) was prepared by its transformation in chemically competent cells Escherichia coli (E. coli) 
strain XL1 blue. Amplification of the clone was done according to the protocol for growing E. 
coli culture overnight in LB medium at 37 °C [35] and purification was performed using Qiagen 
Plasmid plus Maxi kit. Finally, DNA was eluted in 10 mM Tris-HCl buffer and stored at −20 °C. 
The concentration of plasmid DNA (512 ng µL−1) was determined by measuring the absorbance 
of the DNA-containing solution at 260 nm. One optical unit corresponds to 50 µg mL−1 of 
double stranded DNA. 
The cleavage reaction of supercoiled pUC19 DNA with different concentration of 4, 6 and 8 was 
investigated by incubation of 460 ng of plasmid in a 20 µL reaction mixture in 40 mM 
bicarbonate buffer (pH 8.4) at 37 °C, for 90 minutes. The reaction mixtures were vortexed from 
time to time. The reaction was terminated by short centrifugation at 10000 rpm and addition of 5 
µL of loading buffer (0.25% bromophenol blue, 0.25% xylene cyanol FF and 30% glycerol in 
TAE buffer, pH 8.24 (40 mM Tris-acetate, 1 mM EDTA)).  
 
2.12.4. Agarose electrophoresis 
The samples were subjected to electrophoresis on 1% agarose gel (Amersham Pharmacia-
Biotech, Inc) prepared in TAE buffer pH 8.24. The electrophoresis was performed at a constant 
voltage (80 V) until bromophenol blue had passed through 75% of the gel. A Submarine Mini-
gel Electrophoresis Unit (Hoeffer HE 33) with an EPS 300 power supply was used. After 
electrophoresis, the gel was stained for 30 min by soaking it in an aqueous ethidium bromide 
solution (0.5 µg mL−1). The stained gel was illuminated under a UV transilluminator Vilber-
Lourmat (France) at 312 nm and photographed with a Nikon Coolpix P340 Digital Camera 
through filter DEEP YELLOW 15 (TIFFEN, USA). 
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3. Results and discussion 
3.1. Synthesis 
Pentagonal-bipyramidal isothiocyanato complexes of Mn(II) (1), Ni(II) (2), Co(II) (3 and 4), 
Zn(II) (5) and Cd(II) (6) with 2,2’-[2,6-pyridinediylbis(ethylidyne-1-hydrazinyl-2-
ylidene)]bis[N,N,N-trimethyl-2-oxoethanaminium] dichloride (H2LCl2) (Scheme 1) were 
synthesized according to the previously reported methods [19−21]. Iron(III) complexes 7 and 8 
were obtained in the reaction of the ligand H2LCl2, FeCl3·6H2O and NH4SCN (Scheme 2). The 
complexes possess the same pentagonal-bipyramidal complex cation, while the nature of their 
anions depends on mole ratio of NH4SCN and FeCl3·6H2O used in reaction. The complexes were 
characterized by elemental analysis, IR spectroscopy, conductometric measurements and X-ray 
analysis. The observed value of molar conductivity for complex 7 corresponds to 1:1 electrolyte 
indicating stability of PBPY-7 complex cation in solution. The value of molar conductivity for 
complex 8 indicates solvolysis of complex anion [Fe(H2O)(NCS)5]
2– whereby one or two 
coordinated SCN– ligands are replaced with molecules of solvent [36]. 
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Scheme 2. Synthesis of Fe(III) complexes 7 and 8. 
 
3.2. Spectroscopy 
Comparison of IR spectra of H2LCl2 and complexes 7 and 8 indicates symmetric coordination of 
deprotonated bishydrazone ligand. In the IR spectra of complexes 7 and 8 a band corresponding 
to ν(O–C=N) of the deprotonated ligand appeared at 1614 cm–1 instead of the carbonyl band 
from uncoordinated ligand at 1707 cm–1 [37]. Coordination of azomethine nitrogen atoms results 
in bathochromic shift of the ν(C=N) band from 1630 cm−1 in the spectrum of H2LCl2 to 1588 
cm−1 in the spectra of complexes 7 and 8 [37]. In the IR spectra of complexes 7 and 8 broad 
strong bands at 2055 cm−1 and 2040 cm−1, respectively, originate from N-coordinated 
thiocyanate anions [38]. 
 
3.4. Crystal structures 
Both compounds 7 and 8 crystallized in triclinic crystal system with space group P-1. Selected 
bond lengths and angles are listed in Table S2. ORTEP representations of the structures are given 
in Figures 1 and 2. The major building unit in crystal structures of both compounds is complex 
cation where Fe(III) ion is coordinated by ligand L and two SCN– ligands forming distorted 
pentagonal-bipyrimidal coordination geometry. Four fused five-membered chelate rings are 
formed during coordination of pentadentate ligand to Fe(III) ion. In compound 7, the counter ion 
of cationic [FeL(NCS)2]
+ complex is SCN– anion. There are also two solvate water molecules 
per complex cation in the crystal structure. The asymmetric unit of compound 8 consists of two 
complex cations [FeL(NCS)2]
+ per one [Fe(H2O)(NCS)5]
2– anion and four uncoordinated water 
molecules. In the solid state structure of both compounds 7 and 8 cations, anions and 
uncoordinated water molecules are connected by O–H···N and O–H···O hydrogen bonds. 
Complex cations [FeL(NCS)2]
+ in 7 form dimers through the C-H type interactions (H7BCg 
distance is 2.83 Å, where Cg is the center of gravity of the pyridine ring at x, y, 1z). The 
coordination geometry of cationic complex [FeL(NCS)2]
+ is close to other complexes with 
pentagonal-bipyramidal geometry and N3O2 donor sets of ligand H2L
2+ [19–21]. Only the 
distances Fe–O in 7 and 8 are slightly shorter than in other [MH2L(SCN)2]2+ complexes. The 
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complex anion [Fe(H2O)(NCS)5]
2– was also found in (C6H6NO2)2[Fe(NCS)5(H2O)]·2C6H5NO2 
[39] the only known example of complex anion [Fe(H2O)(NCS)5]
2– found in the crystal structure 
[40].  
 
 
Figure 1. ORTEP plot of 7 with thermal ellipsoids at 30 % probability level. Hydrogen atoms, 
water molecules and uncoordinated SCN– ligand are omitted for clarity. 
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Figure 2. ORTEP plot of 8 with thermal ellipsoids at 30 % probability level. Hydrogen atoms 
bonded to carbon atoms and uncoordinated water molecules are omitted for clarity. 
 
3.5. Antimicrobial activity 
The results of antimicrobial activity for Fe(III) complexes 7 and 8 are presented in Table 1. Both 
complexes showed better activity than the ligand H2LCl2 and FeCl3·6H2O, but their MIC values 
were higher than the values for standard antimicrobial agents. Complex 8 exhibited moderate 
activity against all the tested microbial strains. The activity of complex 7 was low to moderate. 
The highest activity of both complexes was observed against B. subtilis. Complexes 8 and 7 
showed better activity against Gram positive than Gram negative bacterial strains. Among the 
investigated compounds only complex 8 exhibits moderate activity against C. albicans. Amount 
of pentagonal-bipyramidal complex cation per mole of compound is twice higher in 8 than in 7, 
but MIC values for complex 7 are not twice of the values for complex 8, indicating that the 
nature of their anions (SCN– in the case of compound 7 and [Fe(H2O)(NCS)5]
2– in the case of 
compound 8) also influence antimicrobial activity. In biological systems peroxidase catalyzed 
SCN– oxidation by endogenous H2O2 results in formation of hypothiocyanite (OSCN
–), which 
possesses antimicrobial activity. Antimicrobial activity of hypothiocyanite is attributed to its 
reaction with sulfhydryl groups of glycolytic enzymes and thiol-based antioxidants [41]. Also, 
hypothiocyanite is the product of non-catalysed oxidation of thiocyanate by hydrogen peroxide 
[42] or ferric ion [43]. In aqueous solution isothiocyanato ligands of complex anion 
[Fe(H2O)(NCS)5]
2– are displaced by water molecules [43]. Free SCN– can be oxidized to 
hypothiocyanite by H2O2 produced in oxidative metabolism of aerobic prokaryotic cells. Also, 
Fe(III) complex species originating from [Fe(H2O)(NCS)5]
2– can oxidize SCN– to OSCN– with 
formation of ferrous species. Fenton reaction [44] of Fe2+ with H2O2 generates hydroxyl radicals 
which have a strong non-selective antimicrobial activity. The fact that complexes 7 and 8 
showed better activity towards Gram positive than Gram negative bacteria, indicates that their 
antibacterial activity depends on the structural features of the bacterial cell wall. Iron(III) 
complexes 7 and 8 showed better antimicrobial activity than pentagonal-bypiramidal 
isothiocyanato Ni(II), Co(II), Zn(II) and Cd(II) complexes [20, 21] with the same 
bis(acylhydrazone) ligand. 
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Table 1. Antimicrobial activity of ligand H2LCl2 and complexes 7 and 8, MIC (mM). 
 
Microorgamisms H2LCl2 FeCl3·6H2O 7 8 Gentamicin Ciprofloxacin Amphotericin 
S. aureus ATCC 6538 1.876 
>3.699 
1.527 0.160 n.t. 0.001 n.t. 
S. epidermidis ATCC 1228 0.938 >3.699 0.382 0.160 0.002  0.002 n.t. 
B. subtilis ATCC 6633 0.938 >3.699 0.382 0.080 0.001 0.002 n.t. 
E. coli ATCC 10536 1.876 >3.699 0.382 0.160 0.001 0.001 n.t. 
K. pneumoniae ATCC 13883 >1.876 >3.699 1.527 0.321 0.008 0.002 n.t. 
P. aeruginosa ATCC 9027 >1.876 >3.699 >1.527 0.321 0.005 0.002 n.t. 
S. enterica NCTC 6017 >1.876 >3.699 >1.527 0.321 0.002 0.002 n.t. 
C. albicans ATCC 10231 >1.876 >3.699 1.527 0.642 n.t. 0.001 0.003 
n.t. – not tested 
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3.7. Cytotoxic activity 
The examined compounds showed concentration-dependent moderate to low cytotoxic activities 
on five tested human cancer cell lines, as well as on normal, non-transformed human fibroblasts 
MRC-5, as presented in Table 2. The cytotoxic activities of the tested complexes were lower 
against all malignant cell lines in comparison with the activity of cisplatin, which served as a 
positive control. The complexes 4, 6 and 8 exerted the most pronounced selective cytotoxic 
effects on all examined cancer cell lines. Human myelogenous leukemia K562 cells were the 
most sensitive to complex 4 with IC50 value of 38.66 µM and complex 8 with IC50 value of 48.33 
µM. Breast carcinoma MDA-MB-453 cells had the highest sensitivity to the cytotoxic activity of 
complex 6, which also exerted the most pronounced cytotoxicity against this cell line with IC50 
value of 59.40 µM. The complexes 4 and 8 also showed pronounced cytotoxic activity on MDA-
MB-453 cells with IC50 values of 76.51 and 87.27 µM, respectively. Human cervical 
adenocarcinoma HeLa cells were the most sensitive to the cytotoxic effects of complexes 4 and 6 
with IC50 values of 70.46 and 71.06 µM, respectively; while complex 8 exerted slightly lower 
activity on HeLa cells with IC50 106.61 µM. Lung carcinoma A549 cells exerted sensitivity to 
the action of complexes 4, 6 and 8 with IC50 values of 79.53, 84.76 and 70.45 µM, respectively. 
The examined complexes did not show selectivity in the cytotoxic activity against cancer cell 
lines in comparison with non-transformed normal lung fibroblasts MRC-5, exerting pronounced 
cytotoxic effects on MRC-5 cells. Complex 6 showed higher activity against A549 cells and 
lower toxicity against normal MRC-5 cell line than Cd(II) salt. Cobalt complex 3 with free 
thiocyanate anion exhibited lower cytotoxic activity than cobalt complex 4 with complex anion 
[Co(NCS)4]
2- and cobalt(II) salt. The activity of complex 4 is higher than the activity of 
cobalt(II) salt. Better activity of complex 4 can be attributed to synergistic effect of PBPY-7 
complex cation and [Co(H2O)6]
2+ formed from [Co(NCS)4]
2- which has low stability in water 
solution [20]. 
Table 2. The cytotoxic activity of the investigated complexes and its precursors. 
 HeLa MDA-MB-453 K562 LS174 A549 MRC-5 
IC50 [µM] mean±S.D. 
1 187.28±18.91 183.33±23.57 190.93±15.71 >200 187.66±21.38 198.35±2.86 
2 186.85±22.77 187.85±17.18 194.51±7.76 170.82±33.19 144.42±7.69 46.79±1.52 
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3 96.75±11.82 135.01±1.55 76.99±10.54 176.90±11.44 129.77±28.30 92.08±7.82 
4 70.46±13.59 76.51±17.69 38.66±3.49 115.25±28.19 79.53±14.47 54.57±14.24 
5 190.10±17.15 111.37±4.74 122.80±0.30 170.72±41.42 130.85±5.77 121.78±14.49 
6 71.06±5.95 59.40±14.21 72.98±6.10 160.46±16.44 84.76±3.08 86.89±13.94 
7 110.98±24.45 115.69±7.86 75.94±5.20 171.84±34.78 98.72±1.55 80.42±0.06 
8 106.61±15.92 87.27±4.06 48.33±6.87 116.11±31.00 70.45±7.60 40.19±0.73 
H2LCl2 >200 >200 >200 >200 >200 >200 
MnCl2·4H2O 156.84±38.49 138.40±30.35 85.07±21.12 192.67±12.70 189.62±7.17 143.62±23.04 
NiCl2·6H2O 76.31±1.09 111.59±2.08 77.76±2.91 136.61±28.97 127.68±27.82 78.75±15.03 
CoCl2·6H2O 95.37±9.56 92.01±12.11 45.73±3.57 136.79±0.45 97.98±12.81 57.58±1.98 
ZnCl2·2H2O >200 191.32±12.27 169.87±28.50 >200 200.00±0.00 105.61±25.82 
Cd(NO3)2·4H2O 79.16±1.62 56.40±11.08 49.16±13.70 112.57±22.16 126.80±15.25 57.27±14.68 
FeCl3·6H2O >200 >200 >200 >200 >200 >200 
cisplatin 4.73±0.88 6.05±1.12 5.63±0.21 24.86±3.41 9.43±0.60 8.56±1.58 
 
 
3.8. Changes in the cell cycle phase distribution  
To explore the mechanisms of cytotoxic effects of the most active complexes 4, 6 and 8, cell 
cycle analysis of HeLa and K562 cells treated with IC50 and 2IC50 concentrations of these 
compounds for 24 h was performed. The changes in the cell cycle phase distribution of these 
cells induced by the chosen compounds are presented in Figure 3. Treatment of HeLa cells with 
IC50 and 2IC50 concentrations of complex 6 induced a statistically significant increase of HeLa 
cells in subG1 cell cycle phase and significant decrease of cells in G2/M phase when compared 
with control untreated cells. The exposure of HeLa cells to complexes 4 and 8 applied at 2IC50 
concentrations led to significant increase in the percentage of subG1 cells in addition to 
significantly reduced percentage of cells in S phase in comparison with control cell sample. 
Furthermore, complexes 4 and 8 caused accumulation of HeLa cells in G1 cell cycle phase, 
although the observed change was not statistically significant. Cisplatin applied at 2IC50 
concentration caused increase in subG1 and S phases and decrease G2/M phase of cell cycle in 
HeLa cells. The complex 6 applied at IC50 and 2IC50 concentrations for 24 h caused G1 cell cycle 
phase arrest in K562 cells, which was statistically significant when compared with untreated 
cells. The accumulation of K562 cells in G1 phase treated with 2IC50 concentration of complex 6 
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was accompanied with significant increase of cells within subG1 phase in addition to 
significantly decreased percentage of cells within S and G2/M phases. Treatment of K562 cells 
with 2IC50 concentration of complex 4 induced significant increase of cells in G1 phase and 
significant decrease of cells in S and G2/M cell cycle phases in comparison with control K562 
cells. Cisplatin applied at 2IC50 concentration caused increase in subG1 and G1 phases and 
decrease in S and G2/M phases of cell cycle in K562 cells. 
 
Figure 3. Changes in the cell cycle phase distribution of HeLa (A, B) and K562 cells (C, D) 
treated with IC50 and 2IC50 concentrations of complexes 4, 6 and 8, and cisplatin (CDDP). The 
results are presented as the mean ± S.D. from three independent experiments. Statistically 
significant differences between control and treated cells are marked with * (p<0.05). Applied 
IC50 concentrations of the tested compounds were: 70.46, 71.06, 106.61 and 4.73 µM, 
respectively for HeLa cells and 38.66, 72.98, 48.33 and 5.63 µM, respectively for K562 cells. 
 
3.9. Morphological evaluation of HeLa cell death mode 
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The examination of morphological changes of HeLa cells treated for 24 h with 2IC50 
concentrations of complexes 4, 6 and 8 demonstrated the ability of these compounds to trigger 
apoptosis in HeLa cells (Figure 4). The pro-apoptotic effect of complex 6 was more pronounced 
in HeLa cells when compared with the effects of complexes 4 and 8, as showed by cell cycle 
analysis as well. Typical morphological hallmarks of apoptosis could be observed in HeLa cells 
incubated with tested complexes, such as rounded cells, shrinkage of the nucleus, chromatin 
condensation and fragmentation of the nucleus in addition to orange-red stained HeLa cells in the 
later stages of apoptosis. Morphological characteristics of apoptosis were also observed in HeLa 
cells exposed to cisplatin.  
 
Figure 4. Photomicrographs of acridine orange/ethidium bromide-stained control HeLa cells and 
HeLa cells exposed to 2IC50 concentrations of the cisplatin (9.46 µM) and complexes 4, 6 and 8 
(140.92, 142.12 and 213.22 µM, respectively) for 24 h. 
 
3.10. Identification of target caspases  
To further elucidate the mechanisms of the cell death mode induced by the complexes 4, 6 and 8 
in HeLa cells, the effects of the pretreatment with specific inhibitors of caspase-3, caspase-8 and 
caspase-9 were examined by cell cycle analysis (Figure 5). Decrease in the percentage of HeLa 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
20 
 
cells within subG1 phase was observed in the samples exposed to complexes 4 and 8 and 
pretreated with the inhibitors of caspase-3, caspase-8 or caspase-9, when compared with the 
percentages of HeLa cells in subG1 phase in the samples which were not pretreated with these 
specific inhibitors. Treatment with complex 6 of HeLa cells pretreated with inhibitors of caspase-
3 or caspase-9 led to remarkable decrease of subG1 cells in comparison with cells which were 
not pre-exposed to inhibitors before treatment with complex 6. However, the pretreatment with 
caspase-8 inhibitor did not reduce the percentage of subG1 cells incubated with this complex. 
Our results point out that complexes 4 and 8 possess the ability to trigger extrinsic and intrinsic 
apoptotic signaling pathways in HeLa cells. The complex 6 induces prominent pro-apoptotic 
effect in HeLa cells through intrinsic apoptotic pathway. The effects of caspase-3 and caspase-9 
inhibitors on the activity of complex 6 in HeLa cells may suggest that this complex could 
activate caspase-independent apoptosis or other cell death types besides apoptosis. 
 
Figure 5. Effects of the specific caspase inhibitors (Z-DEVD-FMK - caspase-3 inhibitor; Z-
IETD-FMK -caspase-8 inhibitor; Z-LEHD-FMK - caspase-9 inhibitor) on the percentages of 
subG1 HeLa cells treated with 2IC50 concentrations of the complexes 4 (A), 6 (B) and 8 (C) 
(140.92, 142.12 and 213.22 µM, respectively). 
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3.11. Effects on the in vitro angiogenesis  
The endothelial cell tube formation assay showed weak suppressive effects of complexes 4, 6 
and 8 applied at sub-toxic IC20 concentrations (200, 50 and 50 µM, respectively) on in vitro 
angiogenesis of EA.hy926 cells (Figure 6). Each of the tested complexes showed the ability to 
inhibit formation of capillary-like tube structures, observed in the control, untreated EA.hy926 
cells. The antiangiogenic effects of complexes 6 and 8 were to some extent more pronounced 
when compared with the effect of complex 4.  
 
 
Figure 6. Photomicrographs of control EA.hy926 cells and EA.hy926 cells exposed to sub-toxic 
IC20 concentrations of the complexes 4, 6 and 8 (200 µM, 50 µM and 50 µM respectively) for 20 
h. 
 
3.12. DNA binding studies 
DNA is one of the main targets of anticancer agents and it is well established that such 
compounds can bind to DNA via both covalent and/or non-covalent interactions. For example, 
cisplatin binds to DNA through covalent bonding via chloride ligand exchange by a nitrogen 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
22 
 
containing guanine base of DNA [45]. Non-covalent interactions include intercalation of a planar 
aromatic moiety between two base pairs of DNA via -stacking, binding to the minor and major 
grooves of DNA, and electrostatic interactions with the negatively charged phosphate backbone 
[46,47]. In this work, spectrophotometric methods were employed to ascertain the interaction 
modes of 4, 6 and 8 with CT-DNA. The absorption spectra of complexes 4, 6 and 8 (Figure 7, 
Panels A, B and C, black lines) exhibit intense absorption bands at about 300 nm and a shoulder 
at 340–380 nm. These bands were unperturbed by the presence of CT-DNA (Figure 7, Panels A, 
B and C, red lines). The observed increase occurring below 300 nm, attributable to DNA 
absorption, shows that interactions between the complexes and double helix exist, accompanied 
by hyperchromism, the value of which reached -9.9%, -16% and -7% for 4, 6 and 8, respectively. 
The percentage of hyperchromism was determined from {[(εDNA + εCOMP) – εB]/ (εDNA + εCOMP)} 
x 100 where εDNA is the extinction coefficient of CT-DNA, εCOMP is the extinction coefficient of 
free metal complex and εB is the extinction coefficient of the bound metal complex. The 
observed negative values for hyperchromism result from possible electrostatic interaction 
between complex cation and the negatively charged phosphate backbone of DNA molecule. 
In order to obtain information on stability of the newly formed complexes 4/CT-DNA, 6/CT-
DNA and 8/CT-DNA, spectroscopic titrations of the solutions of CT-DNA were performed. The 
absorbance at 259 nm was monitored for each concentration of DNA (Figure 7, Panels D, E and 
F). The binding constant Kb was determined using equation (1) (see Experimental Section). The 
intrinsic binding constants Kb of the complex 4 (Inset in Figure 7, Panel D) and of the complex 6 
(Inset in Figure 7, Panel E) were calculated as 1.29×103 M−1 and 6.4×102 M−1, respectively. The 
complexes exhibit similar binding affinity towards DNA. Considering that the values differ from 
the values described in the literature for classical intercalators, for example, ethidium─DNA, 
7×107 M−1 it can be concluded that both complexes bind to DNA via the non-intercalative mode. 
In the case of complex 8 (Inset in Figure 7, Panel F), deviation from linearity might be 
consequence of other processes such as base modification and/or nicks formation.  
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Figure 7. Changes in electronic absorption spectra of the complexes 4 (A), 6 (B) and 8 (C) (1, 2 
and 4 × 10–5M) after interactions with CT-DNA (8.4 × 10–5 M) and determination of binding 
constants by absorption titration of 4 (D), 6 (E) and 8 (F) at fixed concentration (1 × 10–5 M) 
with increasing concentrations of CT-DNA (2.1, 4.2, 6.3, 8.4, 10.5, 12.6, 14.7 and 16.8 × 10–5 
M). The arrows show the changes in absorbance upon increasing amounts of CT-DNA. The 
insets show the linear fit of [DNA]/(εa – εf) vs. [DNA] and the binding constant (Kb) was 
calculated using eqn. (1). 
 
To further clarify the nature of interactions of the complexes with CT-DNA, a displacement 
study was performed. It is known that ethidium bromide (EB) emits intense fluorescent light in 
the presence of DNA due to its strong intercalation between adjacent base pairs. The extent of 
fluorescence quenching of EB by competitive displacement from DNA is a measure of the 
strength of interactions between the second molecule and DNA [48]. The emission spectra of EB 
bound to CT-DNA in the absence and the presence of 4, 6 and 8 are shown in Figure 8, Panels A, 
B and C, respectively. Binding of EB to CT-DNA was evaluated by excitation at 500 nm with 
maximum fluorescence at 600 nm. The fluorescence intensity of the band at 600 nm of EB─CT-
DNA system decreased remarkably with the increasing concentration of the complex 
compounds. The maximal decrease of EB─CT-DNA fluorescence intensity was about 47 %, by 
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4 (Figure 8, Panel A), 41.5 % by 6 (Figure 8, Panel B) and about 46 % by 8 (Figure 8, Panel C), 
suggesting that the three complexes competed with EB in binding to DNA to a similar extent. 
The obtained fluorescence quenching data were analyzed by eqn. (2) (see Experimental section). 
The plots displayed a good linear relationship for the investigated concentration ranges of 4, 6 
and 8. The quenching constants for 4, 6 and 8, were calculated as K= 0.5979, K = 0.5221 and K = 
0.5964, respectively. These data indicate the displacement of ethidium bromide from system 
EBCT-DNA by the complexes, but in view of UV/Vis absorption spectral results it is most 
likely not a consequence of intercalation, but of structural changes in DNA arising from 
electrostatic binding, which reduce the binding affinity of EB [49].  
 
 
Figure 8. Emission spectra of ethidium bromide (EB) (2.5 x 10–5M) bound to CT-DNA (8.4 × 
10–5 M) and quenching of EB−CT-DNA system by 4 (Panel A), 6 (Panel B) and 8 (Panel C) at 
increasing concentrations (1, 2, 3, 4, 5, 6 × 10–5 M). The arrows show that fluorescence intensity 
decreased with increasing concentration of the complex. The insets show fluorescence quenching 
curves of EB bound to DNA at λmax=600 nm by 4 (Panel A), 6 (Panel B) and 8 (Panel C). The 
quenching constants K were calculated using eqn. (2) by linear regression of the plot I0/I against 
[r]/[CT-DNA],where I0 and I represent the fluorescence intensities of EB−CT-DNA in absence 
and presence of the complex, and r = [complex]/[CT-DNA]. 
 
To provide additional insight into the interactions between the DNA and the complexes, the 
study with the minor groove binder Hoechst 33258 was performed. 
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Hoechst 33258 (H) binds strongly and selectively with high affinity to double-stranded B-DNA 
structure and like other minor groove binders, it recognizes at least four AT base pairs. It binds 
by combination of hydrogen bonding, van der Waals contacts with the walls of the minor groove, 
and electrostatic interactions between its cationic structure and the DNA [50]. Binding of 
Hoechst 33258 to CT-DNA was followed by excitation at 350 nm with maximum in 
fluorescence at 444 nm. The fluorescence intensity of the band at 444 nm of the Hoechst−CT-
DNA system decreased remarkably with the increasing concentrations of complexes 4, 6 and 8 
(Figure 9, Panels A, B and C, respectively). The maximal decrease of Hoechst−CT-DNA 
(HCT-DNA) fluorescence intensity by 4 was 64 %, by 6 51 % and by 8 82 %. Results showed 
that the displacement of Hoechst by the complex 8 was more efficient than by the other two 
complexes. Insets in Figure 9, Panels A-C show the quenching plots demonstrating the 
quenching of H bound to CT-DNA by all three complexes are in agreement with the linear Stern-
Volmer Eq. (2) for the investigated concentration ranges of 4 (Figure 9, Panel A), 6 (Figure 9, 
Panel B) and 8 (Figure 9, Panel C). The corresponding quenching constants of HCT-DNA 
system by 4, 6 and 8 were calculated by linear regression of a plot I0/I against r as K= 1.238, K = 
2.5166 and K = 11.4486, respectively. The complex 8 was the most efficient and some deviation 
from linearity might be a consequence of stronger electrostatic interaction in a groove of DNA, 
due to the presence of two mol of complex cation per mole of compound 8. 
DNA binding studies indicate that interactions of the complexes 4, 6 and 8 with DNA occurred 
possibly due to electrostatic interactions between a positively charged quaternary ammonium 
group of the complexes and negatively charged phosphate groups of DNA backbone.  
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Figure 9. Emission spectra of Hoechst33258 (H) (2.5 × 10–5M) bound to CT-DNA (8.4 × 10–
5M) and quenching of H−CT-DNA system by 4 (Panel A), 6 (Panel B) and 8 (Panel C) at 
increasing concentrations (1, 2, 3, 4, 5, 6 × 10–5 M). The arrows show that fluorescence intensity 
decreased with increasing concentration of the complex. The insets show fluorescence quenching 
curves of H bound to DNA at λmax=443 nm by 4 (Panel A), 6 (Panel B) and 8 (Panel C). The 
quenching constants K were calculated using eqn. (2) by linear regression of the plot I0/I against 
[r]/[CT-DNA],where I0 and I represent the fluorescence intensities of H−CT-DNA in absence 
and presence of the complex, and r = [complex]/[CT-DNA]. 
3.6. DNA cleavage 
The type of DNA metal complex interactions has been further established by the investigation of 
damage to circular DNA. The ability of Co(II), Cd(II) and Fe(III) complexes to cleave double-
stranded plasmid pUC19 were investigated using an agarose electrophoretic assay. The assay 
allows assessment of DNA strand cleavage by monitoring the conversion of untreated 
supercoiled form (FI) plasmid DNA into the nicked form (FII) and linear form (FIII). As shown 
in Figure 10 (lanes 1, 7 and 13, panel A; lane 1, panel B), plasmid pUC19 consisted mainly of FI 
and FII. The addition of increasing concentration of complex 4 to the plasmid resulted in the 
bands of these plasmid forms smeared in concentration-dependent way. The result indicated that 
complex 4 has a strong damaging effect, converting DNA to shorter fragments. In the case of 6, 
the conversion of forms I and II becomes a much less efficient with increasing concentration of 
the complex (Figure 10, panel A, lanes 8–12). On the contrary, the strong strand scission activity 
of Fe(III) complex 8 was obtained. As shown in Figure 10, panel A, lanes 14–18, the interaction 
of 8 with supercoiled form of pUC19 generated linear FIII form. The increase in the 
concentration of 8 produced quenching of fluorescence of ethidium bromide in electrophoretic 
bands. In addition, the formation of the forms with lower mobility became apparent. In the 
presence of the increasing concentration of free ligand H2LCl2 (Figure 10, panel B, lanes 2–4), 
changes in intensity and in mobility of supercoiled forms FI and the open circular forms FII of 
plasmid pUC19 were not observed in comparison to the control (Figure 10, panel B, lane 1). The 
results indicate that plasmid DNA damage could be consequence of the activity of the redox 
active complexes 4 and 8. The effect was most extensive with complex of Co(II) (4). 
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Figure 10. Agarose gel electrophoretic analysis of supercoiled forms FI and the open circular 
forms FII of plasmid pUC19 (2.6 × 10–9 M) (lanes 1, 7 and 13, panel A; lane 1, panel B) after 
incubation (1.5 h at 37 oC) with 0.25, 0.5, 1, 1.5 and 2 mM of complex 4, (lanes 2–6, 
respectively, panel A); with 0.25, 0.5, 1, 1.5 and 2 mM of complex 6, (lanes 8–12, respectively, 
panel A); with 0.25, 0.5, 1, 1.5 and 2 mM of complex 8, (lanes 14–18, respectively, panel A) and 
with 0.25, 1 and 2 mM of ligand H2LCl2 (lanes 2–4, respectively, panel B). 
 
4. Conclusion 
Two newly synthesized cationic complexes as well as six previously synthesized with the same 
ligand, having the same pentagonal-bipyramidal geometry, showed moderate to low cytotoxic 
activities towards five tested human cancer cell lines, while the ligand was inactive. Manganese, 
nickel and zinc complexes showed low activity. Cadmium complex was moderately active 
towards MDA-MB-453 breast carcinoma cell line, HeLa cervical carcinoma cell line, K562 
leukemia cell line and A549 lung carcinoma cell line. Considering two cobalt complexes, the 
nature of anion influenced the activity – complex 4 with complex tetraisothiocyanatocobaltate(II) 
anion exerted higher cytotoxic activity on tested malignant cell lines, K562 cells were the most 
sensitive to the activity of this complex. Iron complex 8 with complex anion [Fe(H2O)(NCS)5] 
exhibited higher intensity of cytotoxic activity than iron complex 7, with free thiocyanate anion, 
but in this case, if the results are recalculated for concentration of the complex cation, the effects 
are opposite. The investigated complexes 4, and in particular 6 induced alterations in cell cycle 
phase distribution of HeLa and K562 cells. Cadmium complex 6 caused significant increase of 
apoptotic subG1 cells in both cell lines. Iron complex 8 induced significant changes in cell cycle 
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phase distribution only in HeLa cells. Morphological changes in HeLa cells were also indicative 
of apoptosis, with complex 6 having again the most pronounced effect. Identification of target 
caspases in HeLa cells showed that complexes 4 and 8 trigger extrinsic and intrinsic apoptotic 
signaling pathways, while complex 6 exerts effects through intrinsic apoptotic pathway, but also 
possibly through caspase-independent apoptosis or other cell death types. Complexes 4, 6 and 8 
bind to DNA, most probably by electrostatic interactions, and perturb DNA structure, causing 
displacement of both ethidium bromide and Hoechst 33258. Complexes 4 and 8 cause cleavage 
of plasmid DNA in vitro, while cadmium complex 6 is much less efficient. Cleavage of DNA 
could be provoked by redox activity of complexes 4 and 8 where cobalt and iron are also 
involved in the complex anion. Complexes 4, 6 and 8 also showed a weak antiangiogenic effect. 
Iron (III) complexes 7 and 8 showed a better antimicrobial activity than complexes of other 
metals with this ligand. It is clear the factors that affect certain type of biological activity of 
studied compounds are very complex. Without any doubt type of metal ion is very important 
however, complex anion can also affect results substantially and more studies are needed to 
better understand all these processes. 
 
Acknowledgements 
This work was supported by the Ministry of Education, Science and Technological development 
of the Republic of Serbia (Grant OI 172055 and Grant OI 175011) and Slovenian Research 
Agency (P-0175). We thank the EN-FIST Centre of Excellence, Ljubljana, Slovenia, for use of 
the SuperNova diffractometer. 
 
References 
[1] L.D. Popov, A.N. Morozov, I.N. Shcherbakov, Yu.P. Tupolova, V.V. Lukov, V.A. Kogan, 
Metal complexes with polyfunctional ligands based of bis(hydrazones) of dicarbonyl 
compounds, Russ. Chem. Rev. 78 (2009) 643–658. 
[2] S. Naskar, M. Corbella, A.J. Blake, S.K. Chattopadhyay, Versatility of 2,6-diacetylpyridine 
(dap) hydrazones in generating varied molecular architectures: Synthesis and structural 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
29 
 
characterization of a binuclear double helical Zn(II) complex and a Mn(II) coordination polymer, 
Dalton Trans. (2007) 1150–1159. 
[3] B.A.D. Neto, B.F.L. Viana, T.S. Rodrigues, P.M. Lalli, M.N. Eberlin, W.A. da Silva, H.C.B. 
de Oliveira, C.C. Gatto, Condensed, solution and gas phase behaviour of mono- and dinuclear 
2,6-diacetylpyridine (dap) hydrazone copper complexes probed by X-ray, mass spectrometry and 
theoretical calculations, Dalton Trans. 42 (2013) 11497–11506. 
[4] L.J. Batchelor, M. Sangalli, R. Guillot, N. Guihéry, R. Maurice, F. Tuna, T. Mallah, 
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Synopsis 
Pentagonal-bipyramidal Fe(III) complexes with dihydrazone of 2,6-diacetylpyridine and Girard's T 
reagent have been synthesized and characterized. Cytotoxic activity of Fe(III) complexes and Co(II), Ni(II), 
Mn(II), Zn(II) and Cd(II) complexes with the same ligand was tested. The best activity was observed in 
the case of Fe(III), Co(II) and Cd(II) complexes.  
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 pentagonal-bipyramidal Fe(III) complexes 
 cytotoxic activity 
 effect on cell cycle progression in tumor cells 
 DNA interactions 
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